## COP: ConocoPhillips - XLE: Energy

### Executive Summary

No thesis match: PEG 3.43 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($89.84)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 7, Bearish: 0)

**1. Oil and Gas Redevelopment Project off Norway Gets $1.8B Approval**
- Source: Offshore Engineer Magazine | 20251216T102554 | Bullish | Relevance: 100%
- ConocoPhillips Skandinavia and its partners have approved a final investment decision for the joint redevelopment of an oil and gas project in the Greater Ekofisk Area, offshore Norway, totaling $1.8 billion. The Previously Produced Fields (PPF) Project encompasses the Albuskjell, Vest Ekofisk, and Tommeliten Gamma fields, aiming to recover 90 to 120 million barrels of oil equivalent. First gas is anticipated in the fourth quarter of 2028, with development plans to be submitted in early 2026.

**2. Geneos Wealth Management Inc. Purchases 20,328 Shares of ConocoPhillips $COP**
- Source: MarketBeat | 20251216T093939 | Somewhat-Bullish | Relevance: 100%
- Geneos Wealth Management Inc. significantly increased its stake in ConocoPhillips (NYSE:COP) by 152.9% in Q2, acquiring an additional 20,328 shares, bringing their total holdings to 33,619 shares valued at approximately $3.02 million. This move is part of a broader trend, as several other institutional investors also substantially increased their positions in ConocoPhillips, with institutional investors now owning around 82.36% of the stock. Analysts have a "Moderate Buy" consensus rating for COP with an average price target of $114.54, and the company recently raised its quarterly dividend to $0.84 per share.

**3. Should ConocoPhillipsâ€™ Raised Output and Lower Costs in Q3 2025 Require Action From COP Investors?**
- Source: Simply Wall Street | 20251214T202507 | Bullish | Relevance: 100%
- ConocoPhillips exceeded analyst expectations in Q3 2025, increasing full-year production guidance and lowering operating cost guidance, indicating strong operational performance. Despite industry-wide supply risks, the company also improved Delaware Basin well productivity. This positive report suggests ConocoPhillips is maximizing output, sharpening its investment narrative around its U.S. shale scale and LNG exposure, though potential oversupply issues remain a key risk for investors.

**4. ConocoPhillips (COP): Valuation Check After Q3 2025 Beat and Upgraded Full-Year Guidance**
- Source: Simply Wall Street | 20251213T220758 | Somewhat-Bullish | Relevance: 100%
- ConocoPhillips (COP) reported a strong Q3 2025, exceeding expectations and improving its full-year production guidance while reducing operating cost forecasts. Despite recent share price fluctuations, the company's long-term shareholder return remains robust. The article explores whether ConocoPhillips is undervalued, considering its expanding LNG portfolio and strong future cash flow outlook, but also acknowledges some valuation concerns based on its P/E ratio and execution risks for large-scale projects.

**5. Green light for $1.8 billion oil redevelopment in Norwegian waters**
- Source: Offshore-Energy.biz | 20251216T101154 | Bullish | Relevance: 100%
- ConocoPhillips Skandinavia and its partners have sanctioned a $1.8 billion redevelopment project for previously produced fields (PPF) in the Greater Ekofisk Area on the Norwegian Continental Shelf. This project, which includes the Albuskjell, Vest Ekofisk, and Tommeliten Gamma fields, aims to extend the life of the area and add 90 to 120 million barrels of oil equivalent from 2028 onwards through advanced well technology and subsea tie-backs to the Ekofisk Complex. Plans for development and operation will be submitted in Q1 2026, with first gas expected in Q4 2028.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | UBS | $120 | $117 | +3% |
| 2025-12-12 | Mizuho | $121 | $120 | +1% |
| 2025-12-05 | Johnson Rice | $105 | $108 | -3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | UBS | main | Buy |
| 2025-12-12 | Mizuho | main | Outperform |
| 2025-12-05 | Johnson Rice | down | Hold |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 6 ($0.52M) |
| Sells | 3 ($0.04M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 9.7% (-1.1%)
- Blackrock Inc.: 7.2% (-3.1%)
- State Street Corpora: 5.3% (-2.5%)
- JPMORGAN CHASE & CO: 5.2% (+68.7%)
- Capital Internationa: 3.7% (+18.2%)

### Key Risks

1. Valuation stretched: PEG 3.4x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +2.0% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 3.43 signals overvaluation risk, limited margin of safety. Revenue declining -6% YoY, concerning. Insider buying signal ($0.5M), management confidence. Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $117.9B |
| Beta | 0.33 |
| 52W Range | $79.88 - $106.20 |
| Short Interest | 1.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.43 |
| Forward P/E | 15.1 |
| Current P/E | 14.6 |
| YoY Growth | -3.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 2.0% to 4.0% (+2.0% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 69th percentile. MRS_5 at 0.5% confirms short-term momentum alignment. AM_20 at 3.8% shows strong absolute momentum above own 20MA. Outperforming sector by 4.2pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.61), confirming momentum. RSI neutral at 59. OFD pattern: -MLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 4.03% (CS: 69) | Strong |
| RSI_14 | 59.1 | Neutral |
| MACD Histogram | 0.61 | Bullish |
| vs SMA20 | 1.037x | Above |
| vs SMA50 | 1.052x | Above |
| vs SMA200 | 1.023x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $94.36
- **Stop Loss:** $89.84 (4.8% risk)
- **Target:** $98.88 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 221
- **Position Value:** $20,853.56
- **Portfolio %:** 20.85%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-02-05 (Est: $1.28)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.41 | $1.61 | +14.1% |
| 2025Q2 | $1.36 | $1.42 | +4.7% |
| 2025Q1 | $2.05 | $2.09 | +2.0% |
| 2024Q4 | $1.83 | $1.98 | +7.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*